Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Oncogene ; 40(14): 2567-2580, 2021 04.
Article in English | MEDLINE | ID: mdl-33686238

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) is the first and rate-limiting enzyme in pentose phosphate pathway (PPP), excessive activation of which has been considered to be involved in tumorigenesis. Here, we show that tyrosine kinase c-Src interacts with and phosphorylates G6PD at Tyr 112. This phosphorylation enhances catalytic activity of G6PD by dramatically decreasing its Km value and increasing its Kcat value for substrate glucose-6-phosphate. Activated G6PD therefore augments the PPP flux for NADPH and ribose-5-phosphate production which is required for detoxification of intracellular reactive oxygen species (ROS) and biosynthesis of cancer cells, and eventually contributes to tumorigenesis. Consistently, c-Src activation is closely correlated with tyrosine phosphorylation and activity of G6PD in clinical colorectal cancer samples. We thus uncover another aspect of c-Src in promoting cell proliferation and tumorigenesis, deepening our understanding of c-Src as a proto-oncogene.


Subject(s)
CSK Tyrosine-Protein Kinase/metabolism , Colorectal Neoplasms/enzymology , Glucosephosphate Dehydrogenase/metabolism , Animals , Carcinogenesis , Cell Growth Processes/physiology , Colorectal Neoplasms/pathology , Enzyme Activation , HCT116 Cells , HEK293 Cells , HeLa Cells , Heterografts , Humans , Lipids/biosynthesis , Male , Mice , Mice, Nude , NADP/metabolism , Phosphorylation , Proto-Oncogene Mas
SELECTION OF CITATIONS
SEARCH DETAIL